Login to Your Account

DUBLIN – The recent reform of the notorious double-Irish tax avoidance scheme sends out a clear signal to those companies that currently avail of it, according to a senior tax policy official.
LONDON – After failing to reach the primary endpoint in a 507-patient phase IIb trial in acute coronary syndrome (ACS), Cerenis Therapeutics SA has found a route forward for its CER-001 recombinant high-density lipoprotein (HDL), securing orphan drug status in two variants of an inherited rare disorder that causes HDL deficiency.
LONDON – After a "bake-off" between rival sequencing technologies, the UK government is announcing Friday a £78 million (US$132 million) contract with Illumina Inc. to deliver the equipment and services for its 100,000 Genomes Project.
More EUROPE Headlines

Cast Your Vote

Has biotech’s bubble burst?: